Skip to main content
Fig. 3 | Autoimmunity Highlights

Fig. 3

From: Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases

Fig. 3

Anti-phospholipid IgG antibodies analyzed by line immunoassay (LIA) in 95 subjects including 34 patients with anti-phospholipid syndrome (APS), 41 systemic autoimmune rheumatic disease (SARD), and no adverse APS events, as well as 20 healthy subjects (children) (HS) as control group. 2GPI anti-beta2-glycoprotein I, aCL anti-cardiolipin, aPG anti-phosphatidylglycerol, aPI anti-phosphatidylinositol, aPS anti-phosphatidylserine, aPT anti-prothrombin, OD optical density

Back to article page